Categories Trump Innovent Releases Results of a Phase 3 Clinical Study of Tafolecimab(IBI306)in Chinese Patients with non- Familial Hypercholesterolemia at the American Heart Association (AHA) Scirntific Sessions 2022 – PR Newswire Post author By Admin Post date November 6, 2022 Listen to this article Innovent Releases Results of a Phase 3 Clinical Study of Tafolecimab(IBI306)in Chinese Patients with non- Familial Hypercholesterolemia at the American Heart Association (AHA) Scirntific Sessions 2022 PR Newswire ← Trump-DeSantis Rift Grows, With Dueling Rallies and Name-Calling – The New York Times → Saved Web Pages – Daily Report at 9 p.m. [Inoreader digest]